Michael Ison, MD MS Profile picture
#TxID physician at @NM_IDSteward focusing on donor-derived and viral infections, Director of @NUCATSInstitute CCR & Editor-in-Chief @TheTxIDjournal
Aug 12, 2021 12 tweets 8 min read
As we are on the cusp of authorization of a 3rd dose of #SARSCoV2 #Vaccine for immunocompromised, I think its time for the entire Transplant Community begin focusing on some important questions that this entire situation has brought up

1/X
1. Transplant patients have reduced protection from all vaccines compared to healthy controls, so the poor response was predicted. Why wasn’t there an a priori plan to study this? Many advocated for studies, but there were no @NIH or #Pharma funding mechanisms

2/x